Abstract
Sidra is a third-year medical student studying at Lancaster University. Neurology has always held a special interest for her and in this article she writes on the topic of urinary incontinence from a neurological point of view, looking at the treatment modalities for neurogenic urinary incontinence, focusing particularly on botox and neuromodulation.
References
Guys JM, Breaud J, Hery G, et al. Endoscopic injection with polydimethylsiloxane for the treatment of paediatric urinary incontinence in the neurogenic bladder: long-term results. J Urol 2006;175:1106-10. Available from: https://doi.org/10.1016/S0022-5347(05)00404-0
Bergman J, Lerman SE, Kristo B, et al. Outcomes of bladder neck closure for intractable urinary incontinence in patients with neurogenic bladders. J Pediatr Urol 2006;2:528-33. Available from: https://doi.org/10.1016/j.jpurol.2005.12.001
Sahai A, Khan M, Fowler CJ, Dasgupta P. Botulinum toxin for the treatment of lower urinary tract symptoms: a review. Neurourol Urodyn 2005;24:2-12
Roberts MM. Neurophysiology in neurourolgy. Muscle Nerve 2008;38:815-36
Verpoorten C, Buyse GM. The neurogenic bladder: medical treatment. Pediatr Nephrol 2008;23:717-25. Available from: https://doi.org/10.1007/s00467-007-0691-z
Fader M, Craggs M. Continence problems and neurological disability. In: Getliffe K, Dolman M, Thomas S. Eds. Promoting continence: a clinical and research resource. London: Elsevier Science; 2003: pp338-39
Dong D, Xu Z, Shi B, et al. Urodynamic study in the neurogenic bladder dysfunction caused by intervertebral disk hernia. Neurourol Urodyn 2006;25:446-50. Available from: https://doi.org/10.1002/nau.20238
Kumar A, Chadda RK, Kumar N, Balan S, Srinivasan SP. Clozapine for the treatment of neurogenic bladder. Neurourol Urodyn 2007;26:537-39. Available from: https://doi.org/10.1002/nau.20399
Karsenty G, Denys P, Amarenco G, et al. Botulinum toxin A (BotoxW) intradetrusor injections in adults with neurogenic detrusor overactivity/neurogenic overactive bladder: a systematic literature review. Eur Urol 2008;53:275-87. Available from: https://doi.org/10.1016/j.eururo.2007.10.013
Reddy PR, Borgstein NG, Nijman RJM, Ellsworth PI. Long-term efficacy and safety of tolterodine in children with neurogenic detrusor overactivity. J Pediatr Urol 2008;4(6):428-33. Available from: https://doi.org/10.1016/j.jpurol.2008.05.003
Denys P, Schnitzler A, Roche N. Managing patients with neurogenic detrusor overactivity – a global approach. Eur Urol Suppl 2006;5:691–95. Available from: https://doi.org/10.1016/j.eursup.2006.05.005
Feifer A, Corcos J. Contemporary role of suprapubic cystostomy in treatment of neuropathic bladder dysfunction in spinal cord injured patients. Neurourol Urodyn 2008;27:475-79. Available from: https://doi.org/10.1002/nau.20569
Guerra LA, Moher D, Sampson M, et al. Intravesical oxybutynin for children with poorly compliant neurogenic bladder: a systematic review. J Urol 2008;180:1091-97. Available from: https://doi.org/10.1016/j.juro.2008.05.056
Giannantoni A, Mearini E, Del Zingaro M, Porena M. Six-year follow-up of botulinum toxin A intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results. Eur Urol 2008. Available from: https://doi.org/10.1016/j.eururo.2008.08.048
Mascarenhas F, Cocuzza M, Gomes CM, Lea N. Trigonal injection of botulinum toxin-A does not cause vesicoureteral reflux in neurogenic patients. Neurourol Urodyn 2008:27:311-14. Available from: https://doi.org/10.1002/nau.20515
Schulte-Baukloh H, Schobert J, Stolze T, et al. Efficacy of botulinum-A toxin bladder injections for the treatment of neurogenic detrusor overactivity in multiple sclerosis patients: an objective and subjective analysis. Neurourol Urodyn 2006;25:110-15. Available from: https://doi.org/10.1002/nau.20153
Kessler TM, Danuser H, Schumacher M, Studer UE, Burkhard FC. Botulinum A toxin injections into the detrusor: an e¡ective treatment in idiopathic and neurogenic detrusor overactivity? Neurourol Urodyn 2005;24:231-36. Available from: https://doi.org/10.1002/nau.20105
Comperat E, Reitz A, Delcourt A, et al. Histologic features in the urinary bladder wall affected from neurogenic overactivity – a comparison of inflammation, oedema and fibrosis with and without injection of botulinum toxin type A. Eur Urol 2006;50:1058-64. Available from: https://doi.org/10.1016/j.eururo.2006.01.025
Gonzalez R , Myers S, Franc-Guimond J, Piaggio L. Surgical treatment of neuropathic urinary incontinence in 2005. When, what, and how? J Pediatr Urol 2005;1:378-82. Available from: https://doi.org/10.1016/j.jpurol.2005.04.002
Snodgrass WT, Elmore J, Adams R. Bladder neck sling and appendicovesicostomy without augmentation for neurogenic incontinence in children. J Urol 2007;177:1510-15.Available from: https://doi.org/10.1016/j.juro.2006.11.080
Stoffel JT, McGuire EJ. Outcome of urethral closure in patients with neurologic impairment and complete urethral destruction. Neurourol Urodyn 2006:25:19-22. Available from: https://doi.org/10.1002/nau.20146
Tan H, Stoffel J, Daignault S, McGuire EJ, Latini JM. Ileovesicostomy for adults with neurogenic bladders: complications and potential risk factors for adverse outcomes. Neurourol Urodyn 2008;27:238-43. Available from: https://doi.org/10.1002/nau.20467
Fiori M, Gunelli R, Mercuriali M, Bercovich E. Tension-free vaginal tape and female stress incontinence: further evidence of effectiveness. Urol Int 2004;72:325-28. Available from: https://doi.org/10.1159/000077686
Oerlemans DJAJ, van Kerrebroeck PEV. Sacral nerve stimulation for neuromodulation of the lower urinary tract. Neurourol Urodyn 2008;27:28-33. Available from: https://doi.org/10.1002/nau.20459
Fjorback MV, van Rey FS, Rijkhoff NJM, et al. Electrical stimulation of sacral dermatomes in multiple sclerosis patients with neurogenic detrusor overactivity. Neurourol Urodyn 2007;26:525-30. Available from: https://doi.org/10.1002/nau.20363
Spinelli M, Malaguti S, Giardiello G, et al. A new minimally invasive procedure for pudendal nerve stimulation to treat neurogenic bladder: description of the method and preliminary data. Neurourol Urodyn 2005;24:305-9. Available from: https://doi.org/10.1002/nau.20118